However, treatment directed at TRPV1 significantly alleviated IL-4, IL-5, and IL-13 level in a chronic asthma murine model, while conversely TRPA1 promoted OVA-induced IL-4 production during acute allergic lung inflammation55,56. This evidence concerns the gene IL13 and chronic asthma.